BOK Financial’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.3K Buy
+74
New +$4.2K ﹤0.01% 1013
2025
Q2
– Sell
-18
Closed -$543 – 1239
2025
Q1
$543 Hold
18
– – ﹤0.01% 1217
2024
Q4
$602 Buy
+18
New +$673 ﹤0.01% 1232
2024
Q2
– Sell
-7
Closed -$308 – 1218
2024
Q1
$308 Buy
+7
New +$334 ﹤0.01% 1148
2023
Q4
– Sell
-26,974
Closed -$1.19M – 1284
2023
Q3
$1.19M Sell
26,974
-31,776
-54% -$1.31M 0.03% 409
2023
Q2
$2.41M Sell
58,750
-1,511
-3% -$58.1K 0.05% 307
2023
Q1
$2.15M Buy
+60,261
New +$2.26M 0.05% 339
2021
Q1
$526K Buy
11,710
+4,025
+52% +$224K 0.01% 679
2020
Q4
$435K Sell
7,685
-4,521
-37% -$225K 0.01% 695
2020
Q3
$579K Sell
12,206
-1,813
-13% -$101K 0.01% 587
2020
Q2
$827K Sell
14,019
-5,699
-29% -$317K 0.02% 502
2020
Q1
$932K Sell
19,718
-2,781
-12% -$155K 0.03% 430
2019
Q4
$1.36M Sell
22,499
-2,864
-11% -$171K 0.03% 438
2019
Q3
$1.52M Buy
+25,363
New +$1.65M 0.04% 407
2015
Q3
– Sell
-4,714
Closed -$271K – 863
2015
Q2
$271K Sell
4,714
-78
-2% -$4.96K 0.01% 723
2015
Q1
$305K Buy
+4,792
New +$325K 0.01% 672

Other funds holding IONS

BOK Financial's IONS Position: Q3 2026 in Review

BOK Financial opened a new position in Ionis Pharmaceuticals (IONS) in Q3 2026: 74 shares worth $3.3K. The stake represents ﹤0.01% of the portfolio and ranks #1013 among its holdings. This is a return to the name: BOK Financial previously reported a position in IONS as recently as Q1 2025.

BOK Financial first reported a position in IONS in Q1 2015 and has held it in 16 quarters since. The position peaked at $2.41M in Q2 2023. 464 funds tracked by Wall St. Rank hold IONS as of Q3 2026.

  • BOK Financial held 74 shares of Ionis Pharmaceuticals worth $3.3K as of Q3 2026.
  • Ionis Pharmaceuticals was a new BOK Financial position in Q3 2026.
  • Ionis Pharmaceuticals made up ﹤0.01% of BOK Financial's portfolio in Q3 2026, its #1013 holding.
  • BOK Financial first reported a position in Ionis Pharmaceuticals in Q1 2015 and has held it in 16 quarters since.
  • BOK Financial's Ionis Pharmaceuticals position peaked at $2.41M in Q2 2023.
  • 464 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q3 2026.

Based on BOK Financial's 13F filing for Q3 2026, filed 27 Oct 2026.